Inter-laboratory variability of the measurement of low titer factor VIII:C inhibitor in haemophiliacs: improvement by the Nijmegen modification of the Bethesda assay and the use of common lyophilized plasmas.
Reber
G
G
Aurousseau
M H
MH
Dreyfus
M
M
Delahousse
B
B
Caron
C
C
Trzeciack
M C
MC
Aillaud
M F
MF
Horellou
M H
MH
Laurian
Y
Y
Si
P
P
D000918:Antibody Specificity; D001774:Blood Chemical Analysis / Q000379:methods / Q000592:standards; D002021:Buffers; D005069:Evaluation Studies as Topic; D005169:Factor VIII / Q000276:immunology* / Q000378:metabolism; D005602:France; D006467:Hemophilia A / Q000097:blood / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D015588:Observer Variation
D002021:Buffers; D007518:Isoantibodies; D005169:Factor VIII